GZMB and neoplasm: Tc17 cells (characterised by IL-17A, IL-17F, IL-21, IL-22 production and low levels of granzyme B) [394] have been associated with both anti-tumour (esophageal SCC patients) [396] and pro-tumour activity (HNSCC patients) [397] (Table 2).